NSF/ANSI 455-4:2021
Superseded
View Superseded by
Good Manufacturing Practices for Over-the-Counter Drugs
English
12-01-2021
05-03-2023
This standard is intended to define a standardized approach for auditing to determine the level of compliance of over-the-counter (OTC) drug products to 21 CFR Part 210 Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General and 21 CFR Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals, International Council for Harmonisation of Technical Requirements for Pharmaceutical for Human Use (ICH) Quality Guidelines, 1, 7 and 10, as well as incorporating additional retailer requirements.
| DocumentType |
Revision
|
| Pages |
44
|
| PublisherName |
NSF International
|
| Status |
Superseded
|
| SupersededBy | |
| Supersedes |